NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
12/12/2023
Voltar para busca
Dado oficial do USPTO
BIOSYNTH
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: Estados Unidos
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
30
Atualização mais recente
12/12/2023
Tipo de marca
Verbal
Classes Nice
5
Data de depósito
13/06/2016
Data de registro
12/09/2017
Data de expiração
-
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
12/12/2023
Última transação
12/12/2023
Escritório responsável
United States Patent and Trademark Office
Código da situação
702
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use
Primeiro uso
29/09/2006
Primeiro uso no comércio
29/09/2006
Código do desenho
4
Tipo de titular
03
Localização do titular
Staad, CH
Examinador
GEARHART,DAVID JAMES
Unidade examinadora
M30
Localização atual
TMO LAW OFFICE 112
Titulares e representantes
Titulares
Biosynth AG
Representantes
Tara Reedy Sliva DENTONS US LLP
Classificação técnica
Classes Nice
Classe 5
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Medicinal preparations for photosensitizing agents used as a dermatologic drug or prodrug for the treatment of skin cancer by phototherapy; Chemical reagents for medical and veterinarian use; Chemical reagents for cultures of microorganisms for medical usein culture media for the isolation and identification of the bacteria strain Escherichia coli O157:H7; Chemical preparations for medical purposesfor Cholesterol testing to prevent possible consequences of Hypercholesterolemia such as atherosclerosiscoronary heart disease and other forms of cardiovascular diseases; Chemical preparations for medical purposesfor novel enzyme responsive inhibitors that allow for modifications of the composition of microbial communities; Chemical preparations for medical purposesfor immunology research; Organic chemical preparations for medical purposesimmunomodulatory compounds with anti-inflammatory properties; Organic chemical preparations for medical laboratory analysis purposesfor medical detectionidentification and quantification of strains of pathogenic bacteria; Chemical preparations for medical laboratory analysis purposesfor medical immunological and microbiological blood testing; Chemical preparations for medical laboratory analysis purposesused as a routine medical supplement to blood culture media in vitro to inhibit blood coagulation and to improve the detection limits for individual microorganisms; Chemical preparations for medical laboratory analysis purposesfor medical detection of pathogenic bacteriavarious strains of ListeriaClostridiumBacillus and Staphylococcus; Chemical preparations for medical laboratory analysis purposesfor the medical detection and quantification of bacteria strains of Escherichia coli; Medical preparations for the diagnosis of Staphylococus aureusin particular for Methicillin-resistant Staphylococcus aureus (MRSA); Medical enzyme
Publicações
Histórico de despachos e eventos da marca no USPTO.
30 publicações encontradas
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
12/12/2023
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
12/12/2023
E815
TEAS SECTION 8 & 15 RECEIVED
14/06/2023
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
12/09/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
18/08/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
18/08/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
18/08/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
12/09/2017
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
10/08/2017
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
09/08/2017
SUPC
STATEMENT OF USE PROCESSING COMPLETE
09/08/2017
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
05/08/2017
IUAF
USE AMENDMENT FILED
11/07/2017
EISU
TEAS STATEMENT OF USE RECEIVED
11/07/2017
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
11/07/2017
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
17/01/2017
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
22/11/2016
PUBO
PUBLISHED FOR OPPOSITION
22/11/2016
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/11/2016
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
18/10/2016
ALIE
ASSIGNED TO LIE
17/10/2016
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
30/09/2016
XAEC
EXAMINER'S AMENDMENT ENTERED
27/09/2016
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
27/09/2016
GNEA
EXAMINERS AMENDMENT E-MAILED
27/09/2016
CNEA
EXAMINERS AMENDMENT -WRITTEN
27/09/2016
DOCK
ASSIGNED TO EXAMINER
22/09/2016
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
20/06/2016
NWAP
NEW APPLICATION ENTERED
16/06/2016
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace BIOSYNTH ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.